ask="1.10"
ask_size="600"
average_daily_volume="854415"
bid="1.00"
bid_size="28000"
book_value="1.37"
change="+0.05"
change_from_200_day_moving_average="-1.48"
change_from_50_day_moving_average="-0.50"
change_from_52_week_high="-7.80"
change_From_52_week_low="0.16"
change_in_percent="+4.76%"
close="1.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.31"
ebitda="-61.52M"
eps_estimate_current_year="-1.49"
eps_estimate_next_quarter="-0.37"
eps_estimate_next_year="-1.35"
ex_dividend_date="N/A"
float_shares="36930000"
high="1.15"
high_52_weeks="8.90"
last_trade_date="3/2/2017"
last_trade_price="1.10"
last_trade_size="16831"
last_trade_time="4:00pm"
low="1.00"
low_52_weeks="0.94"
market_capitalization="58.22M"
moving_average_200_day="2.58"
moving_average_50_day="1.60"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="7.00"
open="1.05"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-57.37%"
percent_change_from_50_day_moving_average="-31.25%"
percent_change_from_52_week_high="-87.64%"
percent_change_from_52_week_low="+17.02%"
previous_close="1.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.76"
price_per_sales="4.62"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="3.87"
stock_exchange="NGM"
symbol="RGLS"
volume="685957"
weeks_range_52="0.94 - 8.90"
